Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 12, 2022
Nimbus Therapeutics
|
Series Unknown | $125M | Biotechnology | — |
Jul 13, 2021
Nimbus Therapeutics
|
Series Unknown | $105M | Biotechnology | — |
Jan 7, 2021
Scorpion Therapeutics
|
Series B | $162M | Biotechnology | — |
Oct 26, 2020
Scorpion Therapeutics
|
Series A | $108M | Biotechnology | Yes |
Jun 5, 2018
Nimbus Therapeutics
|
Series C | $65M | Biotechnology | — |